Arvinas Gives Back to Local Greater New Haven Community in Second Annual Impact Day
NEW HAVEN, Conn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that nearly 200 employees participated in the Company’s second annual “Arvinas Impact Day,” a company-wide community service day benefiting organizations in the Greater New Haven area.
- NEW HAVEN, Conn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that nearly 200 employees participated in the Company’s second annual “Arvinas Impact Day,” a company-wide community service day benefiting organizations in the Greater New Haven area.
- "'Arvinas Impact Day' is a reflection of our company's unwavering dedication to community.
- Eight Arvinas volunteers prepared meals to be served to members of the Greater New Haven community.
- Boys & Girls Club of Greater New Haven: Over 20 members of Arvinas worked to enhance indoor and outdoor facilities.